Mainstay Medical Holdings plc today announced the publication of the two-year assessment results from the RESTORE randomized clinical trial of ReActiv8 for the treatment of intractable chronic low back pain. The data show continued improvements in back pain-related disability, pain and quality of life in the ReActiv8 treatment group, and improvements after one year of ReActiv8 therapy in the crossover group that were indistinguishable from the improvements shown by the treatment group at their one-year assessment. The results were published inThe Spine Journal...

Azizi Developments, a leading private developer in the UAE, is unveiling Azizi Florence, a USD 8.1 billion master-planned community marking...

Following the October 1 agreement between Serbia and the United States to strengthen cooperation in artificial intelligence (AI), Telekom Srbija Group is expanding its AI investment and deepening relationships with leading U.S. technology companies as part of its...

Wolters Kluwer, a global leader in professional information, software solutions and services, today announced the appointment ofAlberto de Benito Aznaras General Manager of its Audit & Assurance business, part of...

Vedanta Limited doubledits annual zinc production capacity to 500,000 tonnes 1 inSouth Africathroughan investment of nearly US$ 600 Mnat Gamsberg (Phase II) at Vedanta Zinc International (VZI). Gamsberg has one of the world’s most significant zinc deposits and is VZI’s flagship zinc mine.Inaugurated bySouth African President Cyril RamaphosaandVedanta Limited Director Priya Agarwal-Hebbar,this...